New GIST Studies Look to Overcome TKI Resistance
Fox Chase Researchers Continue Commitment to Rare GIST Tumors
Several enrolling clinical trials are exploring avenues to overcoming TKI resistance.
The management of gastrointestinal stromal tumors (GIST) was revolutionized with the introduction of tyrosine kinase